Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Iraq's oil boom: How juniors beat the majors

As the U.S. gears up to become the world’s top oil producer by 2017, another major energy development is shaking up the energy industry halfway around the globe. It’s happening in Iraq, the world’s third-largest oil exporter ...

Buzz on the Bullboards: Markets struggle in Q1 2023

Despite a solid start to the year, markets on Bay Street and Wall Street have struggled since fresh calendars went up. This week, Canada’s top banks have been pointing to economic pain ahead with higher loan loss provisions and a fall in quarterly prof...

Oil’s Ongoing Struggle at Multiple Resistances. Resolution Just Ahead?

Although crude oil futures moved a bit higher yesterday, the major resistance zone created by three gaps and the 61.8% Fibonacci retracement again stopped the buyers. A pullback followed, and the futures invalidated the earlier breakout above the previous peaks. Tog...

Indexes Struggle and TRAN suggests a possible top

Nearing the end of October, traders are usually a bit more cautious about the markets than at other times of the year. History has proven that October can be a month full of surprises. It appears in 2019 is no different. Right now, the markets are still range bound and appear ...

Biopharma's Phase 3 Trial Results in Migraine 'Robust,' 'Impressive'

These topline data and next steps for the therapeutic are reviewed in a Ladenburg Thalmann report. In a Dec. 30 research note, analyst Matthew Kaplan reported that Ladenburg Thalmann increased its price target on Buy-rated Axsome Therapeutics Inc. (AXSM:NASDAQ) to $...

Could the coronavirus cause the next ‘Arab Spring’?

The rich are getting richer, inequality is on the rise, and the middle class, the backbone of the US economy since the 1950s, is shrinking. In 2018 the three highest-paid chief executives in the United States earned more than the output of several countries. Tesla&Close...

Precious Metals Producers Make Progress, But Costs Are a Constant Struggle

Newmont Goldcorp Corp. (NEM:NYSE, $42.83) is in our portfolio because Newmont acquired Goldcorp. Over the past eight months, it has been active with major sales, including 50% of Kalgoorlie in Australia—Barrick also sold the other 50% just a little before—and Red Lake ...

Wanda Solution: The IoT and AI Evolution of Facility Management

(Image via Visionstate Corp.) There are plenty of unique opportunities for investors out there, but few are so unique that their platform has essentially no direct competition in the marketplace …. Headquartered in Edmonton, Alberta, Canada, Visionstate Cor...

Mar 14th 2020, Silver Chartbook – Feeling Good

Feeling Good All engines stop. After a week like the last, it is important to exit the fright train. Bombarded by news that leave you at best concerned but more likely rather frightened, it is key to change ones state. No good decisions are made from a low energy stat...

Dec 6th 2019, Crypto Chartbook – Staying alert in pat

Staying alert in pat We advocate a contrarian approach based on a time frame confluence system. When this confluence is absent as of right now, we do not open new large size positions. Most of the times we are positioned already and take possibly some reloads. The followin...
1 2 3 4 5 6 7 8 9 10